A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity
Clinical trial NCT07310901 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07310901
- Sponsor
- Corbus Pharmaceuticals Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-04
- Primary completion
- 2026-07-02
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.